Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03206255Completed
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
PrincipalinvestigatorStart date: 2017-07-01
NCT02562508Phase 3Completed
A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
PrincipalinvestigatorStart date: 2015-12-05
NCT01356823Phase 2Completed
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Cervical CancerCervical Intraepithelial Neoplasia
Principalinvestigator

Research Network

Collaboration Network

16 collaborators·18 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ting Wu, Ph. D.

Xiamen University

Similar
6 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+2 more
Collaborated on 2 trials
Similarity Score58%

Jun Zhang, master

Xiamen University

Similar
12 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+2 more
Collaborated on 1 trial
Similarity Score54%

Ting Wu, Ph. D

Xiamen University

Similar
3 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaPersistent Infection+2 more

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Jun Zhang+2 more
Collaborated on 1 trial
Similarity Score54%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical Dysplasia
Similarity Score12%

Juntao Ran

LanZhou University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Xiaojie Ma

Affiliated Hospital of North Sichuan Medical College

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Xiaoying Xue

The Second Hospital of Hebei Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03206255PrincipalInvestigator

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Completed
NCT02562508Phase 3PrincipalInvestigator

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical CancerCervical Intraepithelial NeoplasiaPersistent Infection+2 more
Completed
NCT01356823Phase 2PrincipalInvestigator

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical CancerCervical Intraepithelial Neoplasia
Completed

All 3 trials loaded